RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,298,900 | +66859.5% | 1,819,132 | 0.0% | 0.81% | -23.2% |
| Q2 2023 | $22,848 | -36.0% | 1,819,132 | -16.1% | 1.06% | -39.6% |
| Q1 2023 | $35,726 | -99.9% | 2,169,132 | 0.0% | 1.76% | +2.8% |
| Q4 2022 | $32,406,832 | -33.2% | 2,169,132 | 0.0% | 1.71% | -37.4% |
| Q3 2022 | $48,523,000 | +8.5% | 2,169,132 | -18.7% | 2.73% | -3.6% |
| Q2 2022 | $44,708,000 | -44.0% | 2,669,132 | 0.0% | 2.83% | -31.0% |
| Q1 2022 | $79,887,000 | -2.5% | 2,669,132 | 0.0% | 4.11% | +29.0% |
| Q4 2021 | $81,969,000 | +100.9% | 2,669,132 | +106.2% | 3.18% | +123.4% |
| Q3 2021 | $40,804,000 | -13.8% | 1,294,132 | 0.0% | 1.42% | -14.7% |
| Q2 2021 | $47,352,000 | +5.8% | 1,294,132 | 0.0% | 1.67% | +10.2% |
| Q1 2021 | $44,738,000 | -16.8% | 1,294,132 | 0.0% | 1.52% | -12.3% |
| Q4 2020 | $53,784,000 | +0.9% | 1,294,132 | +3.4% | 1.73% | -6.2% |
| Q3 2020 | $53,321,000 | – | 1,251,959 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |